Acme United (ACU) Q3 2024: Ex-Camillus Sales Rise 4% as Supply Diversification Mitigates Tariff Risk

Acme United’s third quarter underscores a pivotal portfolio transition, with ex-Camillus/Cuda sales up 4% and operational agility on display amid tariff uncertainty. Market share gains in Westcott and DMT offset industrial softness, while the company’s active supply chain relocation and automation investments position it to weather macro and regulatory headwinds. Management signals confidence in continued earnings strength and acquisition capacity heading into 2025.

Summary

  • Portfolio Realignment Drives Underlying Growth: Exiting Camillus/Cuda sharpened focus on core brands, fueling organic sales gains.
  • Tariff Adaptation Accelerates Supply Chain Shift: Rapid supplier diversification and automation blunt potential trade shocks.
  • Westcott and DMT Outperform: Market share wins and new product momentum balance first aid softness and industrial drag.

Business Overview

Acme United is a branded consumer products company specializing in cutting, measuring, and first aid solutions for school, office, industrial, and healthcare markets. Revenue streams are anchored by flagship brands including Westcott, DMT, and a broad first aid portfolio, with sales spanning North America and Europe. The business model relies on product innovation, channel expansion, and operational efficiency, while leveraging both direct manufacturing and global sourcing to drive margin and growth.

Performance Analysis

The third quarter marked a strategic inflection for Acme United, as the completed sale of Camillus and Cuda (hunting and fishing lines) reset the company’s revenue base and revealed underlying momentum in its core brands. Excluding the divested business, sales rose 4% year-over-year, led by double-digit growth in Westcott cutting tools and DMT sharpeners, both benefiting from market share gains in the craft and kitchen channels. The U.S. segment saw 3% growth ex-Camillus/Cuda, while Europe delivered a robust 15% local currency gain, primarily from the office channel.

Gross margin held steady at 38.5%, with nine-month margin improvement attributed to productivity gains in manufacturing and distribution. SG&A expense was well-managed, remaining flat in dollar terms despite inflationary pressures, though as a percentage of sales it ticked up slightly due to lower revenue. Notably, interest expense dropped on a $15 million reduction in average debt, reflecting disciplined capital allocation and use of sale proceeds to strengthen the balance sheet. Net income rose modestly, with EPS contraction explained by share count dynamics and business mix shift.

  • Westcott and DMT Surge: 10% growth in these brands offset softness in industrial first aid and school/office categories.
  • Europe Outpaces North America: 15% sales growth in local currency, driven by office channel wins, signals geographic diversification strength.
  • Gross Margin Resilience: Operational productivity gains and automation investments support margin stability despite macro headwinds.

While overall reported sales declined due to the portfolio change, the underlying trajectory is positive, with core categories gaining share and management confident in ongoing cash flow and earnings strength.

Executive Commentary

"We introduced our latest smart compliance first aid kits this past September at the National Safety Conference. These items use our patented RFID system to monitor real-time consumption and exploration of the components in our first aid kits and permit automatic replenishment of refills. We are excited about the prospects for this next generation product and look forward to seeing its impact on the market next year. To our knowledge, there are no similar products from our competitors."

Walter C. Johnson, Chairman and CEO

"The higher gross margin in the nine months was mainly due to productivity improvements in our manufacturing and distribution facilities."

Paul Driscoll, Chief Financial Officer

Strategic Positioning

1. Proactive Supply Chain Diversification

Acme United is aggressively shifting production out of China, especially for Westcott products, into Southeast Asia (Malaysia, Vietnam, Thailand, Philippines) to mitigate U.S. tariff risk. Existing suppliers and local offices are being leveraged for a seamless transition, while first aid sourcing is expanding into India, Egypt, and U.S. facilities.

2. Automation and Efficiency Initiatives

The company is deploying new automation systems for packing first aid components and lens wipes, alongside warehouse upgrades to boost efficiency and capacity. These moves are aimed at sustaining margin gains and supporting scalable growth.

3. Portfolio Focus and Innovation

With the sale of Camillus and Cuda, management is concentrating resources on high-potential brands, notably Westcott and DMT, both of which are launching new products and capturing share in faster-growing channels. The introduction of RFID-enabled smart compliance kits positions the first aid business for next-generation replenishment solutions.

4. M&A and Balance Sheet Strength

Free cash flow and proceeds from asset sales have reduced net debt by $11 million year-over-year, even after funding the Elite First Aid acquisition and dividend payments. Management highlights ongoing capacity for accretive M&A as a strategic lever.

Key Considerations

This quarter’s results highlight Acme United’s ability to pivot and invest for future growth while managing near-term volatility. The company’s supply chain agility and automation drive are central to its resilience, but market headwinds and category mix shifts demand close monitoring.

Key Considerations:

  • Tariff Exposure Mitigation: Ongoing relocation of sourcing outside China reduces risk but requires continued execution and cost management.
  • Industrial Market Weakness: Softness in U.S. industrial demand pressured first aid sales, with hurricane-driven replenishment providing only a temporary offset.
  • Innovation-Led Growth: RFID-enabled first aid kits and new Westcott/DMT product pipelines offer differentiated value and margin potential.
  • SG&A and Margin Vigilance: Cost control remains a focus as sales mix and inflation could pressure operating leverage.

Risks

Major risks center on trade policy volatility, particularly the potential for expanded U.S. tariffs on Chinese imports, which could disrupt cost structures and supply continuity. Industrial and office channel demand remains uneven, and margin gains from automation may face offsetting inflationary pressures. Execution risk around supply chain transitions and integration of acquisitions such as Elite First Aid also warrants attention.

Forward Outlook

For Q4, Acme United expects:

  • Continued strong earnings and cash flow generation
  • Further progress on supply chain relocation and automation rollouts

For full-year 2024, management maintained a confident outlook:

  • Ongoing balance sheet improvement and readiness for accretive acquisitions

Management cited several factors supporting the outlook:

  • Robust new business pipeline in Westcott and DMT for 2025
  • Smart compliance kit market launch and continued operational improvements

Takeaways

Acme United’s Q3 reveals a business in transition, with underlying growth masked by portfolio pruning but clear execution on supply chain and product innovation. Margin resilience and cash flow generation support both organic and inorganic growth ambitions, though the path forward hinges on demand normalization and successful supply diversification.

  • Core Brand Momentum: Westcott and DMT are outpacing expectations, driven by share gains and new products, providing a buffer against cyclical softness elsewhere.
  • Tariff and Supply Chain Strategy: The company’s proactive relocation of sourcing and investment in automation is a key differentiator versus less agile competitors.
  • Investor Watchpoint: Monitor the ramp of RFID-enabled first aid kits, further supply chain moves, and any macro or policy shocks that could disrupt the current trajectory.

Conclusion

Acme United’s Q3 demonstrates a nimble, innovation-focused approach to navigating portfolio transition and macro uncertainty. With supply chain flexibility, disciplined balance sheet management, and a clear focus on core brands, the company is positioned to capitalize on both organic and acquisition-driven opportunities as it enters 2025.

Industry Read-Through

Acme United’s rapid supply chain realignment and automation push offer a blueprint for mid-cap consumer products firms facing tariff and cost volatility. The company’s ability to shift sourcing across Asia and expand U.S. production highlights the growing necessity of geographic diversification in a deglobalizing environment. RFID-enabled replenishment and first aid kit innovation signal a broader industry move toward smart, data-driven inventory management, with implications for healthcare, office, and industrial suppliers. Persistent industrial demand softness and channel timing volatility are likely to remain headwinds for the sector, reinforcing the value of diversified product and geographic exposure.